Sequential hemibody radiotherapy in poor prognosis localized adenocarcinoma of the prostate gland: a preliminary study of the RTOG.
Ten patients with poor prognosis localized adenocarcinoma of the prostate gland received local regional radiotherapy to the prostate gland followed by sequential radiation therapy to the lower hemibody and the upper hemibody. The treatment technique is presented and its feasibility demonstrated. Five patients are alive, free of disease, with a minimum of 20 months follow-up. The most common adverse effect was prolonged reversible bone marrow suppression.